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Abstract
Background: Arthrofibrosis, occurring in 3%-4% of patients following total knee arthroplasty
(TKA), is a challenging condition for which there is no defined cause. The hypothesis for this study
was that disregulated production of reactive oxygen species (ROS) and nitrogen species (RNS)
mediates matrix protein and DNA modifications, which result in excessive fibroblastic
proliferation.
Results: We found increased numbers of macrophages and lymphocytes, along with elevated
amounts of myeloperoxidase (MPO) in arthrofibrotic tissues when compared to control tissues.
MPO expression, an enzyme that generates ROS/RNS, is usually limited to neutrophils and some
macrophages, but was found by immunohistochemistry to be expressed in both macrophages and
fibroblasts in arthrofibrotic tissue. As direct measurement of ROS/RNS is not feasible, products
including DNA hydroxylation (8-OHdG), and protein nitrosylation (nitrotyrosine) were measured
by immunohistochemistry. Quantification of the staining showed that 8-OHdg was significantly
increased in arthrofibrotic tissue. There was also a direct correlation between the intensity of
inflammation and ROS/RNS to the amount of heterotopic ossification (HO). In order to investigate
the aberrant expression of MPO, a real-time oxidative stress polymerase chain reaction array was
performed on fibroblasts isolated from arthrofibrotic and control tissues. The results of this array
confirmed the upregulation of MPO expression in arthrofibrotic fibroblasts and highlighted the
downregulated expression of the antioxidants, superoxide dismutase1 and microsomal glutathione
S-transferase 3, as well as the significant increase in thioredoxin reductase, a known promoter of
cell proliferation, and polynucleotide kinase 3'-phosphatase, a key enzyme in the base excision
repair pathway for oxidative DNA damage.
Conclusion: Based on our current findings, we suggest that ROS/RNS initiate and sustain the
arthrofibrotic response driving aggressive fibroblast proliferation and subsequent HO.
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Background
A number of factors are known to result in complications
after total knee arthroplasty (TKA), which include preoperative deformity, neuromuscular disease, patient noncompliance with rehabilitation protocol and technical
errors such as component malpositioning [1-4]. A separate portion of the patient population develops arthrofibrosis after TKA, clinically defined as abnormal scarring of
the joint in which the formation of dense fibrous tissue
and tissue metaplasia prevent normal range of motion [411]. For these patients, surgical intervention and revision
arthroplasty leads to a worsening of the fibrotic condition
and eventual disability [4,9,10].
The exact pathoaetiology of arthrofibrosis following TKA
remains elusive. However, aggressive fibroblast proliferation and tissue metaplasia are a hallmark of this condition
[10,12]. Our previous studies highlighted multiple tissue
changes including the presence of pro-inflammatory factors, increased cell proliferation, survival and increased
matrix deposition [11,13]. In addition, we showed that
mast cells, hypoxia and hypoxia-associated oxidative
stress are linked to the progression of the metaplastic
changes, fibrocartilage formation and heterotopic ossification observed in idiopathic arthrofibrosis [13].
Normally, tissue repair occurs through a sequence of coordinated events that lead to the eventual restoration of tissue form and function. The healing response is initiated
by the clotting cascade, which results in the migration of
inflammatory cells (neutrophils and monocytes) to the
site of injury [14]. Inflammatory cell infiltration is followed by the recruitment of fibrocytes that undergo proliferation, differentiation and the ultimate deposition of
an organized matrix [15-17]. Both the migration of
inflammatory cells into the injured tissue and the proliferation of fibroblasts results in the release of cytokines,
growth factors and reactive oxygen and nitrogen species
(ROS/RNS) [18-26]. Thus, an intricate balance between
cell proliferation, matrix production and tissue remodelling is in place during normal healing, and the restoration
of tissue integrity is dependent on the coordinated or 'coupled' function of inflammatory cells responsible for
remodelling, and fibroblasts, the cells responsible for
resynthesis of the matrix. Once the process of healing
nears completion, the majority of the inflammatory cells
undergo apoptosis, the tissue heals and the release of
ROS/RNS and other factors, which are no longer necessary, halts. Therefore, resolution of the inflammatory
response is critical to the restoration of the tissue to a functional state and the prevention of fibrosis [16,17].
Disruption of the ROS/RNS equilibrium, caused by overproduction or inefficient antioxidant response, has been
implicated in the pathoaetiology of fibrotic conditions
including retroperitoneal fibrosis [27], Dupuytren's [28-
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31], scleroderma [32,33] and Crohn's disease [34]. In
addition, chronic inflammation and oxidative stress contribute to genomic DNA damage. In Crohn's disease, this
damage leads to the overexpression of p53, which potentially contributes to the loss of cell cycle control [35].
Our hypothesis was that susceptible patients exhibit
excessive production and/or the inefficient removal of
ROS/RNS after undergoing TKA surgery, which leads to
aggressive fibrosis. Therefore, we performed a series of
interlinked molecular studies to evaluate ROS/RNS modifications, inflammation and ROS/RNS responsive gene
expression as part of the pathogenesis of arthrofibrosis
following TKA.

Results
Patient cohort information
The clinical records of patients were reviewed in detail to
extract variables including age, sex, body mass index
(BMI), years post initial surgery, pre-existent co-morbidities, functional scores (particularly the details of range of
motion) and all other relevant information (Table 1). Ten
patients undergoing uneventful primary TKA were
matched for age, sex and BMI and included as the control
cohort.

There was no correlation between most of the demographic factors, range of motion and the molecular findings in this cohort of patients. The only significant
correlation observed was between range of motion
(ROM) and tissue calcification/bone volume (BV) (Table
1) [13]. As no other correlations were evident, all subsequent analyses were grouped based on patient tissue BV.
The control tissue BV was 0.005 ± 0.01.
Monocyte and lymphocyte infiltration
Histological analysis of the 10 control tissues showed
~1% average inflammatory cell presence (Figure 1A). This
is in contrast to the arthrofibrotic tissues, which showed a
3.0 - 4.0-fold increase in the number of macrophages and
a 3.0 - 9-fold increase in lymphocytes as compared to control (Figure 1B, C, D). The inflammatory response did not
include the infiltration of neutrophils (Figure 2). The
absence of these cells suggests that the inflammation was
not due to infection. Image analysis of the fibrotic regions
(non-calcified areas) showed increased inflammation in
patient tissues in both the low and high BV groups (Figure
1D). The increase in macrophage and lymphocyte numbers were significant in the both BV groups relative to control tissue (P < 0.05).
Expression of myeloperoxidase (MPO) in arthrofibrotic
tissue
Based on the increased presence of macrophages in the
arthrofibrotic tissues, subsequent analyses to determine
the levels of MPO were performed. MPO is an enzyme
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Table 1: Patient information for the arthrofibrotic cohort.

Sex

Males

3

Females

7

Males

63.7 ± 12.5

Females

57.6 ± 3.7

Males

3.0 ± 1.9

Females

2.9 ± 0.9

Males

28.4 ± 1.6

Females

36.4 ± 1.8

Males

53.3 ± 10.8

Females

44.2 ± 6.6

Males

2.04 ± 2.34

Females

3.93 ± 2.47

Average age

Years post initial total knee arthroplasty

Average body mass index (kg/cm2)

Range of motion (0°-100° flexion)

Tissue calcification (bone volume, mm3 of hydroxyapatite)

that produces highly reactive products that mediate chlorination, protein/DNA hydroxylation and protein/DNA
nitrosylation [36-41]. Low levels of MPO were detected in
control tissue macrophages by immunohistochemistry. A
representative tissue image is shown in Figure 3A. Figures
3B and 3C show the elevated expression of this enzyme in
macrophages within the arthrofibrotic tissue. Although
less intense, MPO expression was also observed in the
periarticular fibroblasts, which was not observed in control tissues (Figure 3D). Image analysis revealed a correlative increase in macrophage (based on CD68 image
analysis) and fibroblast expression of MPO in arthrofibrotic patient tissues (Figure 3E). This increase was statistically significant for the high BV group compared to the
control group (P < 0.05) and the low BV group
approached significance.
Fibrotic tissues contain byproducts of reactive oxygen and
nitrogen species
Based on the increased MPO in the arthrofibrotic tissues,
subsequent analysis were performed in order to determine

the levels of ROS/RNS. As direct measurement of ROS/
RNS production in tissues lacks sensitivity and reproducibility, we measured protein nitrosylation and DNA
hydroxylation (8-OHdG), both are end products of ROS/
RNS-mediated reactions. There was no detectable protein
nitrosylation (Figure 4A) or 8-OHdG modifications (Figure 5A) in control tissues by immunohistochemistry. Evident within the fibrotic regions of the arthrofibrotic
tissues were nitrosylated proteins (Figure 4B and 4C) and
cells containing 8-OHdG (Figure. 5B and 5C). The ROS/
RNS-mediated 8-OHdG nuclear modification was localized to regions of high fibroblast density and was significantly increased in tissues in the high BV group (Figure
5D; P < 0.05).
MPO expression and oxidative stress responses of isolated
arthrofibrotic fibroblasts
In order to determine MPO expression specific to the
arthrofibrotic fibroblast population and to analyse oxidative stress, we performed a real-time polymerase chain
reaction (PCR) microarray panel for oxidative stress
Page 3 of 11
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Figure 2 tissue from
Immunohistochemical
periarticular
stain
patients
for neutrophil
with arthrofibrosis
elastase of the
Immunohistochemical stain for neutrophil elastase of
the periarticular tissue from patients with arthrofibrosis. Representative immunohistochemical results are
shown for (A) elastase in the fibrous and (B) in the vascular
regions of the tissue. A positive control of a neutrophil rich
bone marrow sample is shown in (C). Magnification 200×
with 400× insets, micron bar equals 100 μm.

SOD1 is a both a cytosolic and a secreted protein, and
MGST3 is a major intracellular antioxidant enzyme.
Patients
revision,
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Patients were divided into to three cohorts; control
before revision, and based on the amount of tissue
calcification detected by microcomputed tomography, a low bone volume (BV) group and a high BV
group. A - C show representative images of CD68 immunohistochemistry on (A) control tissue and (B) low BV and (C)
high BV arthrofibrotic tissue. Note the large increase in the
presence of macrophages in the fibrotic regions of the high
BV arthrofibrotic periarticular tissue. Image analysis of lymphocytes (Giemsa stain) and macrophage was based on percentage positive per total cell number for each patient
cohort. (D) There was a correlative increase in lymphocyte
and macrophage numbers with tissue calcification. The fold
increases for both BV groups were statistically significant as
compared to control and each other (*; P < 0.05). Magnification 100× insets, micron bar equals 100 μm.
responsive genes (Table 2). In agreement with the immunohistochemical finding, MPO expression levels in the
isolated arthrofibrotic fibroblasts were 2.4-fold higher
than control fibroblasts. In contrast to MPO, the expression of the major anti-oxidant enzyme superoxide dismutase 1 (SOD1) was down-regulated 2.9-fold. A number
of other oxidative stress responsive genes were also disregulated, showing a significantly increased or decreased
expression by arthrofibrotic fibroblasts. Of note was a 7.6fold increase in polynucleotide kinase 3'-phosphatase
(PNKP), an enzyme involved in the base excision repair
pathway for nearly all ROS/RNS-induced DNA mutations,
and an 11.9-fold increase in thioredoxin reductase 1
(TrxR1) expression, an oxidoreductase enzyme that promotes cell proliferation. Finally, there was 21.1-fold
decrease in the expression of another important anti-oxidant, microsomal glutathione S-transferase 3 (MGST3).

Discussion
This study highlights several major findings that are relevant to the pathogenesis of arthrofibrosis. First, histological findings show an increase in the number of
macrophages and lymphocytes in the periarticular tissue
of patients with arthrofibrosis. Second, by demonstrating
the atypical presence of MPO and ROS/RNS products
(oxidized DNA and nitrosylated proteins) in arthrofibrotic tissues, a potentially important mechanism
involved in gene disregulation has been identified.
Finally, by immunohistochemistry and microarray analysis, we show aberrant expression of MPO, SOD1 and
other oxidative stress genes including; TrxR1, PNKP and
MGST3, which all show significant fold changes in
arthrofibrotic fibroblasts. Disregulated gene expression of
the cellular oxidant/anti-oxidant system in fibroblasts
implicates their involvement in the abnormal fibroblast
proliferation, survival and hypertrophic formation of scar
tissue.
No in depth studies have been performed on arthrofibrotic tissue after TKA in order to determine the extent of
inflammation or other molecular mechanisms involved
in this disease process [10,11,13]. However, chronic
inflammation has been associated with the development
of fibrosis in other tissues, such as Dupytren's Contracture
[28,30,31,42,43], Crohn's disease [34] and additional tissues [14,44]. Studies have also linked the development of
arthrofibrosis after anterior cruciate ligament surgery to
the presence of prior inflammation [45] and to an
increased infiltration of T cells within 10 days after post
surgery [46]. Similarly, in intestinal, pulmonary and renal
fibrosis increased numbers of macrophages and mast cells
are found within the granulation tissue during the proliferative stage of wound healing [20,26,27,47]. Our find-

Page 4 of 11
(page number not for citation purposes)

Fibrogenesis & Tissue Repair 2009, 2:5

http://www.fibrogenesis.com/content/2/1/5

Figure
Immunohistochemical
reactive
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4nitrogen
diagnosed
species
analysis
with
byproducts
arthrofibrosis
of reactive
in periarticular
oxygen species/
tissue
Immunohistochemical analysis of reactive oxygen
species/reactive nitrogen species byproducts in periarticular tissue from patients diagnosed with
arthrofibrosis. A-C show representative nitrotyrosine
immunohistochemistry on (A) control tissue and (B) low
bone volume (BV) and (C) high BV arthrofibrotic tissue.
Note the large increase in the presence of nitrotyrosine in
the fibrotic regions associated with tissues containing high
amounts of bone. Magnification 100× for (A-C), micron bar
equals 100 μm.

Figureand
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analysis
phages
arthrofibrotic
3
showing
fibroblasts
tissue
increased
(MPO)
within
immunohistochemistry
expression
the fibrotic
of regions
MPO inand
of
macrothe
image
Myeloperoxidase (MPO) immunohistochemistry and
image analysis showing increased expression of MPO
in macrophages and fibroblasts within the fibrotic
regions of the arthrofibrotic tissue. A - C show representative images for (A) control tissue and (B) low bone volume (BV) and (C) high BV arthrofibrotic tissue. Note the
large increase in the presence of MPO positive macrophages
(round cells) and fibroblasts (elongated cells) in the fibrotic
regions of the 'high' bone arthrofibrotic periarticular tissue.
(D) A representative image of MPO expression in tissue
from the non-arthrofibrotic stiff knee cohort, showing that
MPO was not expressed by control tissue fibroblasts. Image
analysis of the patient cohorts was based on the average percentage positive per total cell number. There was a correlative increase in MPO expression with tissue calcification. The
fold increases for the high BV group were statistically significant as compared to control and to the low BV group (*; P <
0.05). Magnification 100× for (A -C), micron bar equals 100
μm.
ings, that macrophages and lymphocytes are present in
the arthrofibrotic tissue, supports the involvement of
chronic inflammation in the fibrotic process which develops after TKA. The persistence of this local inflammation,
regardless of the number of years post initial surgery, was
tightly linked to increased tissue calcification and
decreased ROM. This association suggests that calcification and chronic inflammation are connected, which has
been previously observed [48-52].
ROS/RNS is a collective term for a growing number of
reactive species [37,53,54]. They are produced by a variety

of pro-oxidant enzymes including MPO, which directly
produces the highly reactive products hypochlorous acid
(HOCl) and chlorine gas (Cl2) [36,55]. These products
react with other ROS/RNS, leading to the generation of
even a greater number of ROS/RNS [36-41,53,54]. In
addition, HOCl and Cl2 have been shown to mediate
modifications of extracellular [56,57] and intracellular
components [40,41]. Specifically, collagen is oxidized by
a reaction with HOCl and Cl2, resulting in the formation
of chlorinated products. These modifications can affect
the organization of the tissue matrix, altering its mechanical properties as well as preventing normal remodelling
and resolution of the injury response. Intracellular modifications by MPO include ROS/RNS-mediated DNA
hydroxylation and other base pair modifications, which
affect gene expression.
In the present study, we show periarticular arthrofibrotic
tissue with macrophages and fibroblasts uncharacteristically expressing high levels of MPO. The over-expression
of MPO by macrophages and non-myeloid cells is also an
aetiology associated with cystic fibrosis and hepatic fibrosis [58,59]. The promiscuous expression in these fibrotic
diseases is associated with a -463G/A polymorphism
within the MPO promoter [58,59]. Individuals can be
born with this polymorphism or develop it as a result of
ROS/RNS-mediated
promoter
mutagenesis
[3641,58,59]. Our findings suggest that MPO expression by
fibroblasts may have a related aetiology and that MPO
may be a driving force in the fibrotic process associated
with arthrofibrosis.

Page 5 of 11
(page number not for citation purposes)

Fibrogenesis & Tissue Repair 2009, 2:5

http://www.fibrogenesis.com/content/2/1/5

cient antioxidant response has been noted in other
chronic inflammatory conditions. If the antioxidant
response is not sufficient, as in Crohn's disease where an
overall increase in ROS/RNS results because of an excessive accumulation of MPO in the tissue coupled with a
decrease in hydroxyl radical scavengers, the balance is
shifted [34]. As a result of the disturbed ROS/RNS equilibrium, the inflammatory and proliferative phases of
wound healing do not resolve and an aggressive fibrotic
response ensues.

sis
periarticular
Figure
Immunohistochemical
species
(ROS)/reactive
5 tissue from
and
nitrogen
patients
imagespecies
analysis
diagnosed
(RNS)
of reactive
with
byproducts
arthrofibrooxygenin
Immunohistochemical and image analysis of reactive
oxygen species (ROS)/reactive nitrogen species
(RNS) byproducts in periarticular tissue from
patients diagnosed with arthrofibrosis. A-C show representative images of 8-OHdG immunohistochemistry on (A)
control tissue and (B) low bone volume (BV) and (C) high BV
arthrofibrotic tissue. Note the large increase in the presence
of 8-OHdG in the fibrotic regions associated with tissues
containing high amounts of bone. Image analysis of the
patient cohorts was based on the average percentage positive per total cell number. (D) The fold increases in ROS/
RNS product formation for the high BV group were statistically significant as compared to control and the low BV group
(*; P < 0.05). Magnification 100× for (A-C), micron bar equals
100 μm.

ROS/RNS play diverse roles in wound healing - they regulate mast cell degranulation and the release of a number
of enzymes, cytokines and growth factors (for example,
transforming growth factor-β and connective tissue
growth factor (CTGF)) that participate in normal wound
healing and fibrosis [23]. They can also directly stimulate
CTGF expression, fibroblast proliferation and matrix production [33,37,60]. In normal wound healing, the majority of inflammatory cells undergo apoptosis, the tissue
heals and the release of ROS/RNS and other factors stop,
thereby ending the cycle of proliferation and allowing for
wound resolution [61]. In the arthrofibrotic tissue, however, we see the presence of inflammatory cells and ROS/
RNS products years after the initial TKA.
We also observed a decreased expression of SOD1, which
can exacerbate oxidative stress. An imbalanced and ineffi-

Since ROS/RNS mediate downstream effects, a second
confounding factor(s) must be involved in disease progression. The other important observation in our study
was the increased hydroxylation of DNA, signifying DNA
modification. Additional supportive evidence for DNA
oxidative damage-induced modifications in arthrofibrotic
fibroblasts was the 7.6-fold upregulation of PNKP, a key
enzyme in the base excision repair pathway [62]. Specifically, PNKP is one of the primary proteins responsible for
repair of oxidatively-induced DNA lesions and single
strand breaks. In addition to the upregulation of PNKP,
the expression of the oxidative stress responsive gene
TrxR1 was increased 11.9-fold in arthrofibrotic fibroblasts. TrxR1 is an oxidoreductase enzyme that promotes
cell growth, down-regulates the function of p53 induced
apoptosis, regulates DNA synthesis and protects against
oxidant damage [63]. Finally, there was 21.1-fold decrease
in the expression of MGST3, an anti-oxidant enzyme that
reduces lipid hydroperoxides and detoxifies lipid peroxidation end products such as 4-hydroxynonenal [64].

Conclusion
There was an increase in inflammatory cell numbers,
MPO expression, ROS/RNS product accumulation and
disregulation of ROS/RNS responsive gene expression.
The overexpression of MPO and the presence of ROS/RNS
products indicates that ROS/RNS production by inflammatory cells and fibroblasts within the arthrofibrotic tissue is excessive, due either to increased MPO or to the
decreased cellular antioxidant expression of SOD1 and
MGST3 or a combination of both. These observations
strongly suggest an imbalance in the oxidant/anti-oxidant
system regulating the normal resolution of the inflammatory and fibroblastic proliferative phases of wound healing. Based on these findings, we believe that aggressive
periarticular fibrosis and unresolved healing in patients
with arthrofibrosis results from an excessive accumulation
of ROS/RNS, ROS/RNS-modified DNA and disregulation
of oxidative stress responsive genes.

Methods
Tissue collection and processing
This multi-centre study used a standardized tissue
retrieval protocol allowing collection and analysis of peri-
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Table 2: Oxidative stress and antioxidant defense polymerase chain reaction array
Protein

Δ Expr

MGST3

-21.1

PTGS2
TPO

Gene
Microsomal glutathione S-transferase 3

GST-III

-8

Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)

COX-2/COX2

-8

Thyroid peroxidase

MSA/TPX

GPX5

-6.06

Glutathione peroxidase 5 (epididymal androgen-related protein)

GPX5

DHCR24

-5.79

24-dehydrocholesterol reductase

Nbla03646/SELADIN1

GPX6

-5.28

Glutathione peroxidase 6 (olfactory)

Gpx6

AOX1

-5.04

Aldehyde oxidase 1

AO/AOH1

STK25

-4.59

Serine/threonine kinase 25 (STE20 homolog, yeast)

DKFZp686J1430/SOK1

NOX5

-4.59

NADPH oxidase, EF-hand calcium binding domain 5

NOX5A/NOX5B

FOXM1

-3.91

Forkhead box M1

FKHL16/FOXM1B

TXNRD2

-3.65

Thioredoxin reductase 2

SELZ/TR

CYGB

-3.4

Cytoglobin

HGB/STAP

OXR1

-3.32

Oxidation resistance 1

Nbla00307

SOD1

-2.89

Superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))

ALS/ALS1

MPV17

-2.89

MpV17 mitochondrial inner membrane protein

SYM1

GPR156

-2.83

G protein-coupled receptor 156

GABABL/PGR28

DUOX2

-2.52

Dual oxidase 2

LNOX2/NOXEF2

PTGS1

-2.52

Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)

COX1/COX3

PRDX2

-2.35

Peroxiredoxin 2

NKEFB/PRP

MPO

2.351

Myeloperoxidase

myeloperoxidase

GPX1

2.462

Glutathione peroxidase 1

GSHPX1

NOS2A

2.764

Nitric oxide synthase 2A (inducible, hepatocytes)

HEP-NOS/INOS

SIRT2

3.102

Sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae)

SIR2L/SIR2L2

NME5

3.403

Non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)

NM23-H5/NM23H5

PRNP

4.387

Prion protein
(p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia)

ASCR/CD230

SGK2

5.924

Serum/glucocorticoid regulated kinase 2

H-SGK2

LPO

6.277

Lactoperoxidase

SPO

PNKP

7.639

Polynucleotide kinase 3'-phosphatase

PNK

TXNRD1

11.85

Thioredoxin reductase 1

GRIM-12/TR

13.3

Glutathione peroxidase 3 (plasma)

GPx-P/GSHPx-3

GPX3
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articular tissues from the knee of patients undergoing revision arthroplasty for arthrofibrosis. The diagnosis of
arthrofibrosis is based on clinical, radiological examination and intra-operative findings [11]. For these patients,
the distinct intra-operative findings are extensive fibrotic
tissue formation that fills the lateral, medial, and parapatellar gutters, generally within 1 year after TKA. In this
study, tissue samples from 10 affected knees and 10 knees
from osteoarthritis (OA) patients undergoing primary
TKA (controls) were retrieved. Primary surgical tissues
controls were chosen for comparison with arthrofibrotic
tissues, as these tissues represent the pre-surgical status,
where normal OA associated inflammation exists but is
not associated with excessive fibrosis or metaplastic
changes [65].
Tissue samples were taken from the periarticular area,
which included the suprapatellar, medial gutter, lateral
gutter and infrapatellar regions. The tissue was wrapped in
sterile saline soaked gauze and transferred, or shipped
overnight on ice, to the laboratory for fixation and
detailed analyses. Tissue from each anatomical location
was cut into 2 × 5 mm pieces and, depending on the
amount of available tissue, four to five pieces of tissue
from one region were placed in a paraffin block. An equal
number and distribution of tissue cubes was used for
fibroblast isolation. Any remaining tissue was flash frozen
in liquid nitrogen and stored at -80°C. Tissue collection
was performed in accordance with the Institutional
Review Board guidelines of the participating institutes.
Microcomputed tomography (μCT) analysis
Each of the paraffin blocks containing tissue were subjected to μCT analysis in order to determine heterotopic
ossification (Scanco μCT 40, Basserdorf, Switzerland),
with an energy of 45 kVp, a current of 88 μA and a 200-ms
integration time producing a resolution of 20 μm3 voxel
size. Each scan comprised a minimum of 500 slices
through the entire paraffin block. In order to achieve
image noise reduction, a constrained three-dimensional
Gaussian filter (sigma 1.2, support 2) was applied. A fixed,
global threshold for analysis was chosen that represented
the transition in X-ray attenuation between un-mineralized tissue (< 225) and the forming bone (230 - 700).
Analysis consisted of defining the outer boundary of the
tissue for each 20 mm section in the sample. For consistency, the same settings and thresholds were used for each
analysis and applied to every sample in the study. Scout,
sagittal and cross-sectional views were examined for evidence of mineralization.
Histochemical stains
Tissues were fixed in 4% paraformaldehyde, dehydrated,
embedded in paraffin and sectioned (6 μm). Paraffin sections were dewaxed, rehydrated and stained with Harris
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Hemotoxylin (Fisher Scientific, MI, USA; Nos 245-678)
and Eosin Y (Fisher Scientific; Nos 245-827) in order to
determine cellularity, vascularization and tissue morphology. Sections were also stained with Wright Geimsa
(Fisher Scientific; Nos 264-985; phosphate buffer pH 6.8
Nos 262-237) in order to determine the inflammatory cell
number and toluidine blue (Sigma, MO, USA; No.
198161) to determine mast cell numbers.
Immunohistochemistry
Paraffin sections (3 μm) were mounted on Fisher Superfrost/Plus slides which were placed in a 58°C oven for 30
min prior to immunostaining. A Ventana Benchmark XT
automated slide stainer (Ventana, AZ, USA; N750BMKXT-FS) was used for the following immunohistochemical staining reactions. The slide stainer was
equipped with an iView DAB detection kit (Ventana) for
immunoperoxidase visualization of the targeted antigen.
Endogenous biotin reactivity in the tissue sections was
blocked using the Endogenous Biotin Blocking kit from
Ventana. After the completion of the staining run, the
slides were briefly washed in a mild dishwashing detergent solution (Dawn; Proctor & Gable, Ohio, USA) to
remove the liquid cover slip solution and processed for
haematoxylin counterstaining using a 1:8 dilution of
Gills-3 haematoxylin solution (Polysciences, PA, USA) for
1 min. Slides immunostained for 8-OHdG antigen were
counterstained with Fast Green Substitute for Light Green
Working Solution (Poly Scientific, NY, USA). Specific
staining conditions were as follows: p53 mouse monoclonal anti-human antibody (clone: Bp53-11; pre-diluted,
37°C for 32 min) (Ventana; 760-2542) (CC1 treatment*
- 1 h); CD68 mouse monoclonal anti-human antibody
(clone: KP-1; pre-diluted, 25°C for 32 min) (Ventana;
790-2931) (CC1 treatment* - 30 min); neutrophil
elastase mouse monoclonal anti-human antibody (clone:
NP57; 1:100 dilution, 25°C for 1 h) (Dakocytomation;
M-0752) (no antigen retrieval); 8-OHdG monoclonal
antibody (1:20 dilution, 25°C for 1 h) (Oxis International, Inc, CA, USA; 24328) (CC2 treatment* - 8 min
then Protease 3 treatment - 16 min); myeloperoxidase
mouse anti-human antibody (1:300 dilution, 25°C for 1
h) (Dakocytomation, CA, USA; A-0398) (CC2 treatment*
- 1 h); and rabbit anti-nitrotyrosine (1:1000 dilution,
37°C for 1 h) (Harry Ischiropoulos, University of Pennsylvania, USA) (CC2 treatment* - 1 h);. *CC2 is a citrate
based buffer, pH 6.0, Protease 3 is a low concentration
solution of a serine protease and CC1 is a Tris buffer with
1 mM EDTA (antigen retrieval reagents, Ventana; 950124). Slides were then mounted in Permount, cover
slipped and evaluated by microscopy. Control tissues to
determine antibody reactivity and conditions included,
human tonsil tissue, bone marrow, normal breast tissue
and breast tumour tissue.
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Image acquisition and analysis
For each patient two to three blocks of tissue from each
anatomical site were sectioned and complete images of
each section (25-30 individual images) were acquired at a
magnification of 20×. Images were acquired with a Retiga
EXi digital-cooled camera with a red, green and blue electronic filter (QImaging, BC, Canada) or with an RT Color
Spot camera (Diagnostic Instruments, MI, USA) on either
a Nikon Optiphot or a Nikon E800 (Nikon, NY, USA).
Image quantification was performed with Image Pro Plus
software (Mediacybernetics, MD, USA), using a customized macro to count diaminobenzidine (DAB) stained
cells and nuclei of cells stained with haematoxylin. A
quantitative value of the inflammatory response was then
presented as the average percent of positive cells (DAB)
per total cell number (haematoxylin) normalized to total
area. The section results for each block from each anatomical site were averaged and site differences compared.
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lated. For pairs with P-values of less than 0.05, there was
a significant relationship between the two variables. All
parameters were evaluated with SPSS software (versionBase 13.0; SPSS, IL, USA).
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In order to evaluate the number of macrophages (CD68)
and MPO positive cells, the number of each in serial sections was compared. If they existed, the counts were corrected for total cell number and total area of the section.
Fibroblast isolation
Equal amounts of tissue were taken from each region and
combined (total weight ~0.5 g). The 2 × 2 cm pieces were
rinsed in Hanks' balanced salt solution to remove any
blood, placed in a 25 ml flask and incubated at 37°C for
4 days in α-MEM with 10% fetal bovine serum, 100 units/
ml streptomycin and 100 units/ml penicillin (Mediatech,
Inc, VA, USA) [66]. Tissue pieces were removed and the
media changed on day 4. Cells were passaged when they
reached approximately 80% confluency. Cells were not
used beyond passage seven.
RT-PCR and comparative analysis
RNA isolation, quantitative SYBR® Green-based real-time
PCR (RT-PCR) oxidative stress and antioxidant defense
array and data analysis were performed by SABiosciences
(Frederick, MD, USA). Fibroblasts isolated from arthrofibrotic tissue and from primary knee tissue (control) were
analysed. The expression level of the three housekeeping
genes, β2-microglobulin, β-actin and glyceraldehyde-3phosphate dehydrogenase, were used to normalize the
data presented.
Statistical analysis
Statistical analysis between groups was performed using a
one way ANOVA for normality and student's t-test for
continuous variables. A level of significance (α), or a Pvalue of less than 0.05, with a 95% confidence interval,
was determined. In order to evaluate correlations for
patient clinical information and individual test values for
each patient, a Pearson correlation coefficient was calcu-
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